Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
SaleCommon Stock | 3 | $484.14 | $1,452.42 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 7 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,918 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
SaleCommon Stock | 124 | $483.58 | $59,963.92 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 6 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,921 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 124 shares of Company stock on April 1, 2020 at prices ranging from $483.35 to $483.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
SaleCommon Stock | 62 | $482.09 | $29,889.58 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 5 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,045 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
SaleCommon Stock | 58 | $480.28 | $27,856.24 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 4 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,107 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
SaleCommon Stock | 69 | $479.00 | $33,051.00 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 3 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,165 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
SaleCommon Stock | 63 | $478.77 | $30,162.51 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 2 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,234 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:05 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionCommon Stock | 1,200 | $30.63 | $36,756.00 |
DisclosureSEC source: 0001237899-20-000015 · edgardoc.xml · nonDerivative · entry 1 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 4 | $469.49 | $1,877.96 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 8 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,043 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 24 | $468.14 | $11,235.36 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 7 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,047 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 24 shares of Company stock on March 30, 2020 at prices ranging from $468.00 to $468.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 19 | $467.51 | $8,882.69 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 6 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,071 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 19 shares of Company stock on March 30, 2020 at prices ranging from $467.00 to $467.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 23 | $466.60 | $10,731.80 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 5 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,090 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 23 shares of Company stock on March 30, 2020 at prices ranging from $466.05 to $466.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 16 | $465.35 | $7,445.60 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 4 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,113 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 16 shares of Company stock on March 30, 2020 at prices ranging from $465.00 to $465.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 9 | $464.49 | $4,180.41 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 3 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,129 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 9 shares of Company stock on March 30, 2020 at prices ranging from $464.14 to $464.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 3 | $463.16 | $1,389.48 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,138 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 3 shares of Company stock on March 30, 2020 at prices ranging from $463.09 to $463.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 22:49 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 2 | $462.80 | $925.60 |
DisclosureSEC source: 0001708138-20-000024 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,141 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 2 shares of Company stock on March 30, 2020 at prices ranging from $462.71 to $462.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 30, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 7 | $486.31 | $3,404.17 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 29 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,799 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F24 · balance_after: Form one of two Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 1,693 | $485.63 | $822,171.59 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 28 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,806 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F23 · price: Represents volume-weighted average price of sales of 1,693 shares of Company stock on March 10, 2020 at prices ranging from $485.12 to $485.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 345 | $484.72 | $167,228.40 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 27 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,499 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F22 · price: Represents volume-weighted average price of sales of 345 shares of Company stock on March 10, 2020 at prices ranging from $484.72 to $484.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 355 | $483.80 | $171,749.00 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 26 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,844 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F21 · price: Represents volume-weighted average price of sales of 355 shares of Company stock on March 10, 2020 at prices ranging from $483.78 to $483.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 100 | $481.68 | $48,168.00 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 25 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,199 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 60 | $480.34 | $28,820.40 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 24 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,299 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 1,651 | $479.60 | $791,819.60 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 23 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,359 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F20 · price: Represents volume-weighted average price of sales of 1,651 shares of Company stock on March 10, 2020 at prices ranging from $479.00 to $479.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 1,469 | $478.43 | $702,813.67 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 22 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,010 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F19 · price: Represents volume-weighted average price of sales of 1,469 shares of Company stock on March 10, 2020 at prices ranging from $478.09 to $478.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 4,735 | $477.50 | $2,260,962.50 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 21 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,479 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F18 · price: Represents volume-weighted average price of sales of 4,735 shares of Company stock on March 10, 2020 at prices ranging from $477.00 to $477.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 7,197 | $476.51 | $3,429,442.47 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 20 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,214 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F17 · price: Represents volume-weighted average price of sales of 7,197 shares of Company stock on March 10, 2020 at prices ranging from $476.02 to $476.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 4,223 | $475.43 | $2,007,740.89 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 19 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,411 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F16 · price: Represents volume-weighted average price of sales of 4,223 shares of Company stock on March 10, 2020 at prices ranging from $475.06 to $475.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 7,060 | $474.52 | $3,350,111.20 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 18 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,634 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F15 · price: Represents volume-weighted average price of sales of 7,060 shares of Company stock on March 10, 2020 at prices ranging from $474.04 to $474.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 8,024 | $473.39 | $3,798,481.36 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 17 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,694 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F14 · price: Represents volume-weighted average price of sales of 8,024 shares of Company stock on March 10, 2020 at prices ranging from $473.02 to $473.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 10,270 | $472.56 | $4,853,191.20 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 16 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,718 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F13 · price: Represents volume-weighted average price of sales of 10,270 shares of Company stock on March 10, 2020 at prices ranging from $472.02 to $472.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 5,258 | $471.34 | $2,478,305.72 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 15 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,988 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F12 · price: Represents volume-weighted average price of sales of 5,258 shares of Company stock on March 10, 2020 at prices ranging from $471.00 to $471.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 5,531 | $470.48 | $2,602,224.88 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 14 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,246 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F11 · price: Represents volume-weighted average price of sales of 5,531 shares of Company stock on March 10, 2020 at prices ranging from $470.05 to $470.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 7,250 | $469.46 | $3,403,585.00 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 13 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575,777 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F10 · price: Represents volume-weighted average price of sales of 7,250 shares of Company stock on March 10, 2020 at prices ranging from $469.03 to $469.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 8,542 | $468.49 | $4,001,841.58 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 12 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 583,027 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F9 · price: Represents volume-weighted average price of sales of 8,542 shares of Company stock on March 10, 2020 at prices ranging from $468.01 to $468.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 10,023 | $467.53 | $4,686,053.19 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 11 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,569 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 10,023 shares of Company stock on March 10, 2020 at prices ranging from $467.00 to $467.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 11,916 | $466.58 | $5,559,767.28 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 10 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,592 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 11,916 shares of Company stock on March 10, 2020 at prices ranging from $466.02 to $466.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 7,068 | $465.45 | $3,289,800.60 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 9 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,508 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 7,068 shares of Company stock on March 10, 2020 at prices ranging from $465.08 to $465.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 5,099 | $464.59 | $2,368,944.41 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 8 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,576 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 5,099 shares of Company stock on March 10, 2020 at prices ranging from $464.09 to $464.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 5,463 | $463.54 | $2,532,319.02 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 7 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,675 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 5,463 shares of Company stock on March 10, 2020 at prices ranging from $463.04 to $463.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 3,317 | $462.43 | $1,533,880.31 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 6 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,138 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 3,317 shares of Company stock on March 10, 2020 at prices ranging from $462.02 to $462.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 20:05 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 1,159 | $461.79 | $535,214.61 |
DisclosureSEC source: 0001708138-20-000021 · edgardoc.xml · nonDerivative · entry 5 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,455 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 1,159 shares of Company stock on March 10, 2020 at prices ranging from $461.12 to $461.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 10, 2020 at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $33.42 | $0.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · derivative · entry 11 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 300 | $482.82 | $144,846.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 10 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,643 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 300 shares of Company stock on March 9, 2020 at prices ranging from $482.51 to $482.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 500 | $479.21 | $239,605.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 9 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,943 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 500 shares of Company stock on March 9, 2020 at prices ranging from $479.05 to $479.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 200 | $476.16 | $95,232.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 8 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,443 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on March 9, 2020 at prices ranging from $476.15 to $476.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 327 | $475.31 | $155,426.37 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 7 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,643 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 327 shares of Company stock on March 9, 2020 at prices ranging from $475.19 to $475.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 73 | $474.88 | $34,666.24 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 6 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,970 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 100 | $471.34 | $47,134.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 5 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,043 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 200 | $470.83 | $94,166.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 4 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,143 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 100 | $469.80 | $46,980.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 3 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,343 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:05 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 200 | $468.14 | $93,628.00 |
DisclosureSEC source: 0001237899-20-000014 · edgardoc.xml · nonDerivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,443 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.